Aerosolized antibiotic therapy for chronic cystic fibrosis airway infections: continuous or intermittent?
- 31 December 2011
- journal article
- review article
- Published by Elsevier BV in Respiratory Medicine
- Vol. 105, S9-S17
- https://doi.org/10.1016/s0954-6111(11)70022-1
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Adherence with tobramycin inhaled solution and health care utilizationBMC Pulmonary Medicine, 2011
- An 18‐month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosisPediatric Pulmonology, 2010
- Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic FibrosisChest, 2009
- Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis centerPediatric Pulmonology, 2004
- Acute renal failure in cystic fibrosis: Association with inhaled tobramycin therapyPediatric Pulmonology, 2002
- A Randomized Double-Blinded Placebo-Controlled Crossover Trial of Nebulized Taurolidine in Adult Cystic Fibrosis Patients Infected withBurkholderia cepaciaJournal of Aerosol Medicine, 2002
- Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosisPediatric Pulmonology, 1989
- Inhaled ceftazidime compared with gentamicin and carbenicillin in older patients with cystic fibrosis infected with Pseudomonas aeruginosaRespiratory Medicine, 1987
- Antibiotic prophylaxis in cystic fibrosis: Inhaled cephaloridine as an adjunct to oral cloxacillinThe Journal of Pediatrics, 1982